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ABSTRACT 
 
Post-Traumatic Stress Disorder (PTSD), depression, and insomnia are prevalent 
among United States (US) military veterans.  This study investigates whether 
Brain Boosters, a new cognitive enhancement group therapy, improves symptoms 
of PTSD, depression, and insomnia among veterans completing the groups. 
 The study population includes 64 US military veterans treated in the setting of 
the Veterans Affairs (VA) Health Care System in Phoenix, AZ.  Group members 
were US military veterans, age 22 to 87 (mean age=53.47), who had served in or 
after World War II (WWII), who sought mental health care at the Phoenix VA 
from 2007 through 2011.  Participants were treated with Brain Boosters therapy. 
They completed measures of mental-health related symptoms before and after this 
therapy. Participants were assessed pre and post group with the PTSD Checklist 
for military personnel (PCL-M), the Patient Health Questionnaire (PHQ-9; a 
measure of depression symptoms), and the Insomnia Severity Index (ISI). 
Statistical analyses were done with paired samples t-tests and McNemar’s tests, 
using SPSS. The hypotheses were that symptoms of PTSD, depression, and 
insomnia would show statistically significant improvement with Brain Boosters 
therapy. Results supported the hypotheses that symptoms of PTSD and depression 
would improve significantly. Insomnia did not show significant improvement. 
The results showed the mean PCL-M score was 54.84 before Brain Boosters 
therapy and 51.35 after (p= 0.008). The mean PHQ-9 score was 15.21 before 
Brain Boosters therapy and 13.05 after (p= 0.002). The mean ISI score was 15.98 
before Brain Boosters Therapy and 14.46 after (p= 0.056). Although this is a 
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nonrandom, uncontrolled trial, findings nevertheless suggest that Brain Boosters 
may be an effective therapy to reduce PTSD symptom severity and depression 
symptom severity.  This may be especially important for veterans seeking 
alternatives to pharmacological intervention or traditional therapeutic 
interventions.        
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Evaluating Brain Boosters 
 
A New Cognitive Enhancement Program 
 
for Treating Post-Traumatic Stress Disorder and Depression 
  
Post-Traumatic Stress Disorder (PTSD), depression, and insomnia are prevalent 
among United States (US) military veterans (Hoge et al., 2004; Germain, Buysse, 
& Nofzinger, 2008).  Epidemiological surveys indicate that for Operation 
Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) veterans, high rates 
of PTSD, depression, and related conditions are present (Pietrzak et al., 2010).  
Approximately 25% of OEF/OIF veterans receiving care at VA Health Care 
Systems meet criteria for one or more distinct mental health diagnoses.  The most 
common diagnosis is PTSD (Bushnell and Goren, 2011).  This study investigates 
whether Brain Boosters (BB), a new cognitive enhancement group therapy, 
improves symptoms of PTSD, depression, and insomnia among veterans 
completing the groups.  The goal of this research was to assess the effectiveness 
of BB. 
Background 
Brain Boosters  
Development of program. Brain Boosters was developed by Dr. MaryLu 
Bushnell, Psy.D. and Dr. Kathleen Goren, Ph.D., in 2007.  The genesis of BB 
occurred when demand from OEF/OIF/Operation New Dawn (OND) veterans 
with traumatic brain injury (TBI), in need of cognitive rehabilitation, support 
therapy, and education, arose (Bushnell & Goren, 2011).  This population of 
veterans presented post deployment with a rate of TBI between 10% and 23% in 
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returning OEF/OIF veterans (Reisinger, Hunt, Burgo-Black, and Agarwal, 2012).  
Neuropsychological evaluations were identifying cognitive deficits with unclear 
etiologies.  Many evaluations yielded no signs of cognitive dysfunction, but 
veterans were experiencing daily difficulties in functioning.  Existing treatment 
for mild cognitive problems was found to be lacking.  BB was originally designed 
for OEF/OIF veterans with blast exposure (Bushnell & Goren, 2011).  A need was 
identified and these neuropsychologists sought to treat it in a creative, unique, 
way that had not been done before.  Given strong enthusiasm for BB, it was 
opened to all interested veterans.   
  Veterans self refer to these groups and referrals are made from 
neuropsychologists, mental health workers, primary care physicians, social 
workers, and recruitment flyers.  Caregivers, spouses, or other friends/family 
members who provide the veteran with support are encouraged to attend 
(Bushnell & Goren, 2011). 
Program rationale. BB seeks to provide education, “exercise” for the 
brain, tools to re-train oneself in daily activities of life, and an improvement in 
cognition and memory.  The educational component of BB emboldens 
participants to obtain an increased understanding of various etiologies of 
cognitive functioning (Bushnell & Goren, 2011).  One example of this, taught in 
BB, is neuroanatomical structure and functioning.  Research indicates that 
education is the first step in intervention for residual deficits incurred from TBI 
(Khan, Baguely, & Cameron, 2003).  The content of the BB sessions are 
described in the Method.   
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 Implementation of compensatory strategies is taught to participants in BB.  
The information and tools provided from group can be applied to daily life. 
Participants are rallied to identify personal strengths to compensate for deficits. 
Finally, practice skills are taught through experiential activities to improve 
cognitive, personal, and psychological functioning (Bushnell & Goren, 2011). 
 The creators note that similar programs have shown success in addressing 
the needs of this population, including the deleterious effects on psychiatric and 
cognitive functioning, a need for increased life satisfaction, and increased use of 
compensatory strategies (Bushnell & Goren, 2011). In my review of the literature 
I did not find any treatments quite like BB.  The creators of BB (Bushnell & 
Goren, 2011) conjectured the following, “By providing Psychoeducation and 
teaching both compensatory strategies and cognitive rehabilitation strategies, it is 
hypothesized that the veteran will develop habits that will promote continued 
cognitive growth following completion of the program” (p.7).  Along with the 
confidence and self-efficacy gained through participating in this group, veterans 
are presented with connections to resources to help sustain and further their 
growth.  Referrals for resources within and outside of the VA for further 
education, support, and rehabilitation are offered.            
Overview of program. The goal of BB is to assist veterans in learning to 
help themselves to re-train their brains to function more efficiently.  It is geared 
towards veterans with perceived cognitive deficits, regardless of etiology or level 
of impairment.  Each session has a didactic and experiential (fun, computer, 
technology etc.) component.  Strength based focus and generalization to daily life 
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are pillars of BB.  Groups are designed to be meaningful, practical and fun 
(Bushnell & Goren, 2011).   
Prior to beginning sessions, pre measures are completed and collected for 
baseline assessments of PTSD, depression, insomnia, attention and memory, 
combat exposure, and strengths and weaknesses.  Post measures are collected 
after the tenth session to help assess the effectiveness of BB.  Symptom severity 
scores are measured from the outset of BB to the culmination.  Assessing the 
effectiveness of BB and other treatments for PTSD and comorbid disorders or 
features is so important because veterans depend on this knowledge to inform 
higher quality treatment and practice guidelines.  This unique blend of cognitive 
enhancement, psychoeducation, self-efficacy, resilience, positive coping, social 
support, and CBT like therapy is unlike any other and an exciting advancement in 
the field.   
The present study focuses on the effectiveness of BB in reducing 
symptoms of PTSD, as well as symptoms of depression and insomnia, which are 
highly comorbid with PTSD. Therefore, the sections below review PTSD 
symptoms, neurobiological correlates, and treatments.  Factors that are potential 
mechanisms, through which BB may relate to symptom reductions, such as 
through increased problem-focused coping, social support, and self-efficacy, are 
also discussed.  
PTSD Criteria, Symptoms, and Consequences 
PTSD diagnostic criteria. Veterans are particularly vulnerable to PTSD, 
especially those who have been exposed to combat.  PTSD is characterized by 
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intrusive recollections of the traumatic event and avoidance.  To meet clinical 
significance for a diagnosis of PTSD, multiple criteria must be met, as assessed 
by a clinician.  The diagnosis of PTSD requires exposure to a traumatic event and 
symptoms from each of three symptom clusters: intrusive recollections, 
avoidant/numbing symptoms, and hyper-arousal symptoms (DSM-IV-TR, 2000).  
These symptoms are marked by psychological and physiological consequences.  
Next, the two criteria mentioned above include experiencing, witnessing, or being 
confronted with an event that caused or had the potential to cause death or serious 
injury to oneself or others, coupled with feelings of horror, intense fear, and 
helplessness (DSM-IV-TR, 2000).  These two criteria represent Criterion A, 
which concern the stressor itself.  PTSD symptom duration (Criterion E) is 
determined as acute or chronic and requires that symptoms from the three 
symptom clusters have been present for at least a month.  Finally, global 
functioning (Criterion F) is assessed, which relates to the veterans’ ability and 
aptitude to function in the workplace, individually, and in social settings with 
peers, coworkers, family, and friends; even in everyday settings like buying 
groceries amongst strangers.  
Symptoms and consequences associated with PTSD. Dekel and Monson 
articulate an important point; individuals who do not have a diagnosis of PTSD 
may experience a range of sub-diagnostic symptom severity.  Consistent with this, 
many studies examine PTSD symptom severity rather than diagnosis (Dekel and 
Monson, 2010).  Potential symptoms or consequences of PTSD experienced by 
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the individual are outlined in the next paragraphs, as stated by Kennedy and 
colleagues (2007).   
Cognitive symptoms include confusion, memory impairment, 
forgetfulness, impaired concentration, attention difficulties, learning and decision 
making problems, slower processing speed, and the potential consequence of 
feeling overwhelmed with previously simple tasks.  Behavioral symptoms include 
impaired work and school performance, reduced relational intimacy, and a 
potential consequence of relational conflict from social withdrawal, and 
alienation.  Somatic symptoms include headaches, exhaustion, insomnia, and 
exaggerated startle response, along with hyperarousal, musculoskeletal, 
gastrointestinal, and cardiovascular disorders (Kennedy et al., 2007).   
These symptoms are only a fraction of those associated with PTSD. After 
studying PTSD and health outcomes, Jakupcak, Luterek, Hunt, Conybeare, and 
McFall (2008) impart, even after accounting for demographic factors, combat 
exposure, chemical exposure, and health risk behaviors, PTSD is significantly 
associated with poorer health. 
Veterans with PTSD face numerous obstacles to regain their mental 
health.  PTSD has debilitating effects on individuals’ family and social 
functioning (Tiet et al., 2006).  Daily life can become a struggle, in which the 
individual and their family suffer.      
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Prevalence of PTSD 
In the United States, a nationally representative study conducted by 
Kessler and colleagues found that over the life course, 5% of men experience 
PTSD, while 10% of women do; whereas, almost half of adults report having 
experienced a traumatic event.  Other lifetime prevalence studies estimate a 
current PTSD prevalence rate of 15% among Vietnam veterans, 2%-10% among 
Gulf War veterans, and 3%-4% among civilians (Hoge et al., 2004).  Wolfe, 
Keane, Kaloupek, Mora, and Wine (1993) obtained, that 15% of male, Vietnam 
theater veterans continue to suffer from PTSD.  This disparity may be explained 
by a combination of individual differences, environmental influences, and genetic 
predisposition.  In striking comparison, a national survey of Vietnam veterans 
conducted by Kulka and colleagues reported that 31% of males and 26% of 
females had PTSD from their military service (Ozer & Weiss, 2004).    
This illustrates the exceptional number of veterans, as compared to 
civilians, who experience PTSD.  Of the veterans studied in meta-analyses by 
Ozer and Weiss, the strongest predictor of PTSD was peritraumatic dissociation, 
part of the intrusive recollection symptom cluster. Peritraumatic dissociation 
refers to unusual experiences during or immediately after the trauma, such as an 
altered sense of self, time stretching out, or the sense that things around oneself 
are not real (Ozer & Weiss, 2004). Sensations like these are representative of 
many other adverse symptoms associated with PTSD.  
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PTSD and Combat Exposure  
As a population, veterans are at heightened risk for developing PTSD.  
Those who have been in combat and personally witnessed the hell of war, as 
General Sherman said, are even more vulnerable to acquire the disorder.  Vietnam 
veterans with the greatest exposure to combat had the highest rates of PTSD.  
Likewise, Gulf War veterans with greater exposure to combat had a higher 
likelihood of PTSD (Stein et al., 2005). Rodrigues and Renshaw (2010) point out 
that service members’ PTSD symptom severity scores are significantly positively 
related to their amount of combat exposure.  As discussed in the PTSD and Social 
Support section below, greater social support is one of the strongest correlates for 
lower PTSD symptom severity.  Fascinatingly, this is particularly true for 
veterans exposed to combat (Erbes, Polusny, MacDermid, & Compton, 2008).  
The higher the exposure to combat, the greater the potential for payoff from tools 
like social support. 
Studies have been conducted to determine the differences between combat 
exposed veterans with PTSD and without PTSD.  In a study by Blake, Cook, and 
Keane (1992) neither group reported using a significantly different amount of 
problem-focused coping.  However, veterans with PTSD relied more on emotion-
focused coping, including escape avoidance and accepting responsibility, as 
compared to veterans without PTSD.  Wolfe et al. (1993) divided soldiers into 
four groups: high combat/high symptoms, high combat/low symptoms, low 
combat/high symptoms, and low combat/low symptoms.  The high symptoms 
groups reported using significantly higher levels of mental escapism, 
9 
externalization, and extensive behavioral avoidance, more so than either of the 
low symptom groups.  The results of this study indicated that soldiers exposed to 
high combat reported significantly greater distress and endorsed increased 
cognitive analysis of trauma.  Neither combat exposure nor war zone stressors 
were the strongest predictors of functioning.  Instead, a variable reflecting 
detrimental coping strategies was the strongest predictor.  Veterans who endorsed 
externalization, extreme avoidance, and wishful thinking were significantly more 
symptomatic than veterans who were primarily reliant on active forms of coping.   
The implications of these findings warrant therapy designed to encourage 
use of problem-focused coping, rather than emotion-focused approaches such as 
avoidance, as mentioned in the coping section, below.  It is evident that increased 
combat exposure leads to increased PTSD and comorbid symptom severity.  
Thus, combat exposed veterans, especially those with PTSD and comorbid 
features need treatment to encourage the formation of problem-focused attitudes 
and actions.    
Physiological Mechanisms of PTSD 
The physiological mechanisms behind PTSD contributing to 
psychological states, such as dissociation are important to grasp before exploring 
the adverse symptoms of the trauma induced disorder.  Rauch, Shin, and Phelps 
(2006) point out that although the origin of PTSD has historically been defined by 
the traumatic event associated with the disorder, evolving models of pathogenesis 
have brought to light the potential interaction between intrinsic individual 
vulnerabilities, the traumatic event or events, and past experiences.  A 
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neurocircuitry model proposed by Rauch and colleagues posits that 
hyperresponsivity occurs within the amygdala to threat-related stimuli.  The 
ventral/medial prefrontal cortex (vmPFC), subcallosal cortex, orbitofrontal cortex 
(OFC), and hippocampus exhibit poor top-down governance over the amygdala, 
as a result of the trauma.  These inadequacies in governance explicate the 
deficiencies experienced by individuals with PTSD for the following reasons: 
When the amygdala is not capable of controlling hyperresponsivity, the flood 
gates for hyperarousal are opened, explaining the indelible quality of emotional 
memory for the trauma; next, inadequate vmPFC functioning inhibits the capacity 
to suppress attention and response to trauma cues, as well as deficits in extinction; 
third, decreased hippocampal volume, and in turn function, underlie deficits in 
identifying safe contexts, and explicit memory use.  PTSD can be conceptualized 
as a fear-conditioning process, whose toll is visible in neurological structure and 
functioning (Rauch et al., 2006).  In support of the fear-conditioning process, 
Vaiva and colleagues agreed that in the immediate aftermath of a trauma, a surge 
of catecholamines, including adrenalin and noradrenalin are released.  These 
activating neurotransmitters are triggered by the central nucleus of the amygdala 
and locus coeruleus, two key brain structures of the ‘neurocircuitry of fear’.  
Prolonged adrenergic activation increase risk for PTSD through two avenues: 
increased fear conditioning and overconsolidation of memories of the traumatic 
event (Vaiva et al., 2003).  Trauma induced changes in neurophysiologic and 
psychological functioning, as described above, can have lasting effects on the 
brain, the individual, and their families and support systems.   
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PTSD Treatment 
Several types of therapeutic interventions have been proven effective at 
moderating the long term consequences of PTSD, including: Cognitive Processing 
Therapy (CPT), Cognitive Behavioral Therapy (CBT), Prolonged Exposure 
Therapy (PE), Eye Movement Desensitization and Reprocessing Therapy 
(EMDR), Virtual Reality Exposure Therapy (VRE), and Group Therapy.  The 
treatments above are a fraction of those available.     
A variety of individually focused treatment options exist for PTSD.  A 
study by Carlson, Chemtob, Rusnak, Hedlund, and Murakoa (1998) found that 
EMDR evidenced significant improvement of PTSD symptoms in combat 
veterans at a three month follow up; greater improvement than those given routine 
care or bio-feedback assisted relaxation.  Virtual Reality Exposure Therapy 
(VRE) is a promising treatment. Reger and Gahm (2008) believe the capacity for 
the incorporation of new information, due to enhancement and activation of the 
patient’s fear structure by a multisensory computer experience is a potentially 
powerful clinical tool to treat PTSD. Objective assessment showed a decline in 
patient reported PTSD symptom severity. The incorporation of new information is 
necessary to promote growth of more positive neuronal networks, resulting in 
new, more positive thought processes, moving away from engrained, negative 
thought processes.  
A monthly gathering at Walter Reed was designed (Musgrove, 2007) for 
recovering soldiers to socialize and use VRE gaming technology. One veteran 
mused, “When you’re just sitting in your room thinking about what happened, it 
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drives you crazy… this is something to get your mind off your sorrows… I wish 
they had it every week.” (p.2)  EMDR and VRE are less conventional methods of 
treatment, versus more established treatment options like CPT, PE, and CBT.    
 CPT is a very popular line of treatment for PTSD. Chard, Schumm, 
Owens, and Cottingham (2010) endorsed the consensus by the International 
Society for Traumatic Stress Studies Practice Guideline, that CPT is a best 
practice model.  They assert that CPT has strong empirical evidence for treating 
symptoms of PTSD, trauma related distress, and depression.  This is the case 
across populations and treatment settings, including veterans seeking care.  CPT 
includes both cognitive and exposure components, borrowing from CBT and PE. 
  Interestingly, CPT has shown statistically significant improvements 
compared to PE for trauma related aspects of guilt like lack of justification and 
hindsight bias.  During CPT, a range of emotions resulting from traumatization 
are focused upon, as well as anxiety, allowing for the veteran to attempt to 
emotionally process the event and regain control (Monson et al., 2006).  Like 
CPT, CBT is also helpful for allowing patients to regain control.   
Knaevelsrud and Maercker (2007) advocate that CBT is a powerful and 
effective method of treating PTSD.  CBT uses techniques and strategies to help 
patients correct negative and often distorted views.  Underlying maladaptive 
beliefs that give rise to negative and distorted cognitions are targeted (Elkin et al., 
1989). These include views about themselves, the world, and the future.  If CBT 
and CPT, a form of CBT are not successful in treating symptoms of PTSD, 
Prolonged Exposure is another common method of therapeutic intervention. 
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PE is a somewhat more radical approach to treatment; although, a 
potentially effective one.  While undergoing PE therapy, patients may be asked to 
revisit the trauma associated with their PTSD symptoms.  This can be done by 
talking in the first-person, present tense, about what they experienced.  Also, by 
focusing on what they could smell, hear, feel, see, and taste.  Finally, by 
remembering their response, the meaning they may have found in the event and a 
host of other feelings linked to the trauma.  Whatever has generated the most 
intrusive thoughts is addressed and visited with the therapist, head on.  Trauma 
related stimuli are presented to the patient in the hope of lessening or even 
extinguishing the fear and intrusion of trauma related cues (Marks, Lovell, 
Noshivani, & Livanou, 1998).  While the treatments listed above can be thought 
of as primary therapeutic tools to lessen PTSD symptom severity, an integral part 
of achieving wellness lies with the use of secondary therapeutic tools.  Most 
importantly, secondary tools include social interaction, social recognition, and 
social support.  Also, feelings of self worth and self efficacy gained through 
psychoeducation and other outlets.  Finally, coping style, an often under 
recognized tool, wielded to overcome PTSD, along with attribution style.  Coping 
style, social support, familial support, peer support, self-efficacy, cognitive 
enhancement, and psychoeducation are further explored in the sections to follow. 
BB incorporates components from PTSD treatments above, including: 
CBT, CPT and VRE.  PE and EMDR are not used, likely because their 
therapeutic quality would be hindered or infeasible in a group setting.  Elements 
of CBT, and some from CPT practiced in BB are, self awareness, behavioral 
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recognition and modification, positive thinking, focusing on strengths versus 
weaknesses, and asking for and using support.  The use of technology and gaming 
systems is encouraged, like in VRE.   
Obstacles to seeking treatment for PTSD. In a study conducted by Hoge 
et al. (2004), the authors learned that of Operation Enduring Freedom (OEF) and 
Operation Iraqi Freedom (OIF), only 23% to 40% of soldiers positive for mental 
disorders sought mental health care.  Interestingly, subjects reported stigma as the 
greatest barrier to seeking mental health services.  It is imperative that efforts are 
made to reduce stigma, and that therapeutic interventions to lessen PTSD 
symptom severity are further explored to provide better care for Veterans of 
WWII, Korea, Vietnam, the Gulf War, Afghanistan, Iraq, and other conflicts. The 
goal of BB is to approach treatment in a less stigmatizing way.  Despite numerous 
unpleasant and in some cases, life altering symptoms, an arsenal of treatments 
exist to combat adverse symptoms characteristic of PTSD.  
BB as treatment for PTSD. As mentioned, there are a variety of 
individually focused PTSD treatment options.  Also, group therapy can be used 
for social or peer support, marriage and family therapy, and other forms of less 
internally focused therapies.  What seems to have been lacking is somewhat 
individually focused treatment in the context of a group setting.  Dr. Goren and 
Dr. Bushnell, neuropsychologists at the Phoenix VA, sought to bridge this gap 
and fill in the spaces where they believed treatment could be improved.  Cognitive 
enhancement and psychoeducation for veterans to lessen PTSD symptom severity 
has been largely missing from the literature.  Although BB was not designed 
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specifically to treat PTSD, it may be an improvement from the treatments above 
because education is presented as the foundation to build self-efficacy, cope in 
more positive ways, improve attention, memory, learning and cognition, decrease 
symptoms associated with PTSD, depression, and insomnia and foster support.  
The belief is that knowledge is power (Bushnell & Goren, 2011).  Knowledge 
helps empower the individual to achieve their personal goals, to lessen PTSD and 
depression symptom severity, and actively seek wellness.  Part of attaining 
wellness is to practice using positive forms of coping.  
PTSD and Coping 
Coping style has a significant effect on PTSD symptom severity and 
health outcomes.  Chronic PTSD increases stress and heightens demands on 
coping resources.  Participants in BB are taught to recognize their coping style 
and work toward using more positive forms of coping.  According to Hyer, 
McCranie, Boudewyns, and Sperr (1996), “Coping is defined as the person’s 
cognitive and behavioral efforts to master, ameliorate, or tolerate external and 
internal demands, and conflicts created by stressful person-environment 
transactions” (p. 300). There are two primary types of coping, problem-focused 
and emotion-focused.  Problem-focused coping attempts to resolve or alter the 
stressor.  Emotion-focused coping attempts to manage the distressing responses 
evoked by the stressor (Lazarus & Folkman, 1987).  Stressors can be approached 
and engaged or avoided and disengaged.     
Individuals with PTSD experience distressing and intrusive recollections 
of the traumatic event, enduring in the active memory, posing an ongoing threat, 
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perpetuating chronic stress (Hyer et al., 1996).  Working to use advantageous 
forms of coping instead of less adept forms is taught in BB, thereby creating the 
potential to reduce overall stress. 
Several researchers have sought to better understand the relationship 
between chronic PTSD and coping style.  Prior research indicating that avoidance, 
a type of emotion-focused coping has been related to poorer psychological 
outcomes for trauma survivors, motivated Rodrigues and colleagues to study 
associations between coping, combat exposure, and PTSD among National Guard 
veterans deployed overseas since 2001 (Rodrigues & Renshaw, 2010).  In a 
similar study, Tiet and colleagues examined approach coping, functioning 
outcomes and relationships between coping and PTSD (Tiet et al., 2006).  Wolfe 
et al. (1993), interested in coping style, PTSD, and health outcomes, studied 
readjustment patterns in Vietnam veterans who felt that they had adjusted 
adequately to daily life since their deployments.  They were interested in what 
differentiated the well adjusted veterans from those who were not.  Blake et al. 
(1992) studied coping styles and mental health treatment histories of veterans 
diagnosed with PTSD.  They sought to identify the type of coping style war era 
veterans with and without PTSD were most likely to use. 
Results from the studies mentioned above agree, avoidant coping is 
hallmark of increased PTSD severity, while problem-focused coping reduces 
symptoms (Blake et al., 1992; Rodrigues et al., 2010; Tiet et al., 2006; Wolfe et 
al., 1993).  In another study, Hyer and colleagues found that escape-avoidance 
was the most frequently used strategy, followed by self-control, distancing, 
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accepting responsibility, and confrontive coping. Greater symptom severity was 
significantly correlated with greater use of escape-avoidance.  These emotion-
focused and avoidant coping strategies accounted for three-fourths of subjects’ 
coping efforts in dealing with Vietnam War memories.  Planful problem-solving, 
seeking social support and positive reappraisal were the least frequently used 
coping methods (Hyer et al., 1996).  BB teaches veterans to execute planful 
problem-solving, make positive reappraisals and seek social support.  These types 
of non-avoidant coping are characteristic of well adjusted veterans (Wolfe et al.).  
Whereas, use of avoidant coping seems to prevent individuals from fully 
processing events emotionally, problem-focused coping allows for a sense of 
mastery over the event, through control over self and the experience (Stein et al., 
2005).   
Tiet et al. (2006) found that approach coping is instrumental in improving 
functioning of patients with chronic PTSD and is predictive of better family and 
social functioning, despite chronic PTSD symptoms.  More cognitive avoidance 
was indicative of greater PTSD symptoms; PTSD symptoms not only predicted 
more behavioral avoidance coping, but also predicted greater use of approach 
coping. Approach coping includes: making plans, trying to work things out, and 
focusing on positive aspects of a situation, while actively confronting difficult 
situations.  Similarly, active task-oriented coping decreases behavioral 
withdrawal, emotional disengagement, and avoidance symptoms, serving to 
enhance adaptation and limit stress (Pietrzak et al., 2010).  These findings suggest 
approach coping should be encouraged in treatment.  BB encourages approach 
18 
coping and promotes the use of problem-focused coping, control over the self, and 
self-efficacy through psychoeducation.  Tiet cited that higher IQ, hardy 
disposition, social resources or support, family resources, and adaptive coping 
contribute to more positive health outcomes related to PTSD symptom severity 
(Tiet et al., 2006).  
In summary, individuals suffering from PTSD who used problem-focused 
coping scored higher, while those who predominantly used emotion-focused 
coping scored lower on self-reported and clinician rated outcomes.  Approach 
coping seems to decrease PTSD symptom severity by promoting the use of 
problem-focused coping strategies, discouraging avoidant, maladaptive behaviors.  
  Changes in coping strategy influence changes in PTSD symptom 
severity.  With the help of their families, friends, and peers, the transition to 
improved mental health is less arduous. The use of non-avoidant coping implicitly 
suggests seeking social support, both instrumental and emotional.  
PTSD and social support. The coping literature examined above has 
made evident that approach and non-avoidant coping are important to reducing 
PTSD symptom severity.  Pietrzak et al. (2010) state that effective coping 
strategies may be fostered through social support by limiting avoidant coping, 
involvement in risky behavior, reducing feelings of loneliness, and promoting 
self-efficacy. For service members with PTSD, longitudinal research suggests that 
interpersonal relationship problems are their fastest rising concern (Dekel & 
Monson, 2010).  The provision of early social support may reduce the known 
increase in PTSD and comorbid conditions, postdeployment for OEF/OIF 
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veterans (Pietrzak et al., 2010).  BB invites veterans to bring any form of social 
support to groups, including: family, friends, and loved ones who can provide 
emotional or instrumental support.  Instrumental and emotional, two forms of 
social support seeking, offer distinctive benefits.  Instrumental support may be 
financial, whereas emotional support can be derived from simply talking to a 
friend or peer.  Interestingly, Laffaye and colleagues observed that among 
Vietnam veterans, lack of social support, regardless of the type, is a posttrauma 
risk factor for development of PTSD.  Among Gulf War veterans, higher PTSD 
symptom severity was correlated with greater erosion of social support; whereas, 
social support was not predictive of later PTSD symptom severity.  This erosion 
of social support was most significant with perceived interpersonal resources from 
friends who were not veterans.  Social support may come from a variety of 
individuals, but in this study, positivity from friends was found to be 
exceptionally helpful to recovery (Laffaye, Cavella, Drescher, & Rosen, 2008).  
Social support protects against PTSD and depression.  Meta-analyses suggest 
social support is among the most compelling negative predictors of PTSD 
(Pietrzak et al., 2010).  Knowing we are not alone is often enough to potentiate a 
more positive affect.  
PTSD and familial support. For many veterans, the consequences of and 
stress of deployment do not resolve when they return home (Erbes et al., 2008).  
Dekel and Monson (2010) state that a solid base of evidence recognizes the 
association between PTSD symptoms and poorer family functioning, and 
significant other relationships.  Intriguingly, these results are found with respect 
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to different wars, in different countries at different times.  BB encourages veterans 
to utilize familial support by bringing family members to the groups.    
Monson and colleagues have honed in on PTSD and the effects on 
intimate relationships.  Luckily, greater attention has been brought to the 
consequences on intimate relationships and loved ones, along with the 
consequences of trauma on their military counterparts, because of the wars in Iraq 
and Afghanistan.  Studies have documented an association between caregiver 
burden and PTSD symptoms (Monson, Taft, & Fredman, 2009).  BB invites 
family members to attend groups, along with their veteran.  To mediate symptoms 
of PTSD, supportive interactions with family are crucial.  Familial support has 
been found to reduce PTSD symptom severity across trauma levels (Laffaye et al., 
2008).  Individual therapy results are even impacted by the familial environment 
(Monson et al., 2010).  Thus, the more positive the environment, the better for 
individual treatment outcomes.   
PTSD, peer support, and group psychotherapy. Group psychotherapy 
is a popular and widespread form of therapy, whose rationale is based on the 
provision of, and opportunity for validation and support from peers.  Laffaye et al. 
(2008) illustrated that veterans’ peers are a highly valued and important piece of 
PTSD patients’ social networks.  Participants reported receiving a roughly equal 
amount of instrumental assistance from relatives and veterans; however, veteran 
peers were their most common source of emotional support.  Veterans rated 
relationships with their peers as supportive and relatively stress free in 
comparison with marital, non-veteran peer, and familial relationships (Laffaye et 
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al.).  As well as peer support, unit support, a tightly knit version of peer support 
may enhance feelings of self-efficacy, personal control, and meaning making, 
increasing their ability to reappraise stressful events (Pietrzak et al., 2010).  The 
innate understanding of other warriors’ tribulations and experience allow for 
support that is often unrivaled in strength.   
PTSD, resilience, and self-efficacy. Support can also be garnered from 
within, a belief supported in BB.  Psychological resilience is an individual’s 
ability to successfully adapt to adversity.  Both resilience and social support may 
best work together to protect against PTSD and depressive symptomatology by 
reducing hypothalamic-pituitary-adrenal (HPA) axis reactivity and other stress 
related physiological arousal.  Facets of resilience subsume active coping, 
meaning-making, cognitive flexibility and exercising positive emotions (Pietrzak 
et al., 2010).  Resilient individuals are apt to be self-efficacious in nature.   
Self-efficacy is central to being human.  It is the belief that we have the 
ability to exercise control over events that affect our lives and that we are capable 
of managing our own functioning (Benight & Bandura, 2004).  In sum, self-
efficacy is the conviction that we control our own destiny.  Self-efficacy regulates 
functioning through decisional, motivational, cognitive and affective processes.  It 
can dictate the quality of our emotional lives, willingness to persevere and the 
choices we are faced to make (Benight & Bandura).  When feelings of self-
efficacy are low, the consequences are far reaching.  Benight and colleagues refer 
to a study by Solomon and colleagues that longitudinally followed the effects of 
battlefield traumatization on perceived self-efficacy.  The traumas these soldiers 
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witnessed and experienced decimated their perceived efficacy to cope.  The less 
self-efficacy they reported the more intrusive recollections and adaptational 
difficulties they bore (Benight & Bandura). Pietrzak and colleagues conclude that 
individuals with PTSD often have lower coping self-efficacy than those who do 
not have PTSD, which positions them at heightened risk for intrusive and 
avoidance symptoms, and greater distress (Pietrzak et al., 2009).  BB teaches the 
utilization of cognitive flexibility through cognitive restructuring, asks patients’ to 
acknowledge positive attributes about themselves, and make attempts to actively 
cope with stress, strongly encouraging self-efficacy building tactics. 
PTSD and psychoeducation. In order to strengthen and build self-
efficacious values and practice analogous behaviors, psychoeducation can be 
employed.  The International Society for Traumatic Stress Studies established 
practice guidelines for PTSD (Foa, Keane, Friedman, & Cohen, 2008).  Prior to 
distribution of these guidelines, Rosen and colleagues surveyed VA medical 
centers to ascertain their practice guidelines for the treatment of PTSD.  
Psychoeducation was listed as one of the six most often used practices (Rosen et 
al., 2004).  However, the psychoeducation literature is sparse.  Perhaps this is 
where the present study of BB fills a need.  BB uses psychoeducation to 
encourage self-efficacious beliefs amongst veterans participating in the groups.  
Cognitive enhancement is used, as well.   
PTSD and cognitive enhancement. Cognitive enhancement therapy 
(CET), described by Hogarty, Greenwald, and Eack (2006) is a developmental, 
small group approach to the remediation of neurocognitive and social-cognitive 
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deficits.  They endorse that there is a widespread belief that cognitive deficits 
limit recovery.  A study was designed to compare CET with another form of 
treatment, enriched supportive therapy (EST).  The creators of BB deem it a 
cognitive enhancement therapy; a multidimensional, developmental treatment for 
neurocognitive and social cognitive deficits.   
The CET literature has been most influenced by research with 
schizophrenic and Traumatic Brain Injury (TBI) patients.  BB was developed with 
TBI as a primary target for treatment.  CET attempts to do the following: increase 
active processing, mental stamina, and appropriate, spontaneous, negotiation of 
social challenges.  Experiential exercises utilize verbal and non-verbal cues, 
teaching the patient facility to actuate the thoughts, feelings and likely behaviors 
of others, through perspective taking.  Social cognition is sculpted by judging 
affect, reevaluating personal affect, reciprocity, forming shared understanding, 
and appraising social context.  CET discourages concrete cognitive processing, 
advocating more flexible abstraction of relationship themes, addressing 
incomplete or incorrect schemas about others.  Hogarty and colleagues found that 
CET effect sizes on cognition and behavior exceeded those for other cognitive 
rehabilitation treatments.  CET was superior to EST for improvement and 
maintenance of processing speed, social cognition, social adjustment and 
cognitive style (Hogarty et al., 2006).  CET seems useful for treating patients who 
experience neurocognitive challenges with TBI, PTSD, and severe combat 
exposure.                     
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PTSD and Comorbid Features 
 Unfortunately, the presence of one or more comorbid disorders is the rule 
for patients with PTSD, not the exception.  For those with a diagnosis of PTSD, 
the most common comorbidity is depression, followed by substance use and 
personality disorders (Dekel & Monson, 2010). 
PTSD and depression. Depression is characterized as a mood disorder.  
For the aim of this paper, Major Depressive Disorder (MDD) is referenced.  Five 
or more symptoms, occurring within the same two week period, representing a 
change from baseline with at least one of the following symptoms: depressed 
mood or loss of interest or pleasure is necessary for a diagnosis of MDD.  At least 
five of the following nine symptoms must be endorsed: depressed mood most of 
the day, nearly every day; diminished interest or pleasure in all or almost all 
activities; significant weight loss or gain; insomnia or hypersomnia; psychomotor 
agitation or retardation; fatigue or loss of energy; feelings of worthlessness or 
excessive guilt; diminished ability to think or concentrate or indecisiveness, and 
recurrent thoughts of death (DSM-IV-TR, 2000).  Dunn and colleagues (2007) 
indicate that for many disorders, comorbid depression worsens prognosis.  
Depression and PTSD share core features, strengthening the rationale for 
concurrent treatment.  Low self esteem, social withdrawal, helplessness, and 
anhedonia or loss of pleasure, co-occur with PTSD and depression.  BB offers 
strategies to target symptoms of each of these disorders with content to lesson 
symptom severity across each of the ten group sessions.  Next, insomnia, a 
comorbid feature of PTSD and depression is discussed.   
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PTSD and insomnia. One associated symptom of PTSD producing poor 
health outcomes from sleep deprivation, especially in veterans with chronic 
PTSD, is insomnia. Germain and colleagues state that mounting evidence for 
sleep disruption post trauma may constitute a specific mechanism for the 
pathophysiology of chronic PTSD and poor clinical outcomes (Germain et al., 
2008).  Primary insomnia is characterized by a complaint of difficulty initiating or 
maintaining sleep or the indication of nonrestorative sleep for at least one month.  
This disturbance or subsequent fatigue must cause clinically significant 
impairment.  Impairment refers to significant distress, social, and occupational 
functioning.  The sleep disturbance must be exclusive of other sleep disorders, as 
well as mental disorders and medical conditions.  Finally, the disturbance must be 
exclusive of the effects of substance use (DSM-IV-TR, 2000).   
Insomnia and PTSD exacerbate the symptoms of one another, along with 
depression.  Haynes and colleagues note that the relationship between sleep and 
stress has been explored in multiple studies.  This is applicable to individuals with 
PTSD because, increased stress is associated with decreased slow wave sleep, 
which is theorized to be restorative and an increased number of arousals during 
sleep (Haynes, McQuaid, Ancoli-Israel, & Martin, 2006).  A lack of restorative 
sleep and increased awakenings lead to poorer daytime functioning; thereby, 
establishing deficits in daily life. 
LaMeerlo, Sgoifo, and Suchecki (2008) recall controlled studies having shown 
that acute sleep deprivation strongly affects emotionality and cognitive 
functioning.  Chronis sleep loss may induce neurobiological changes over time, 
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resulting in serious health consequences.  Insomnia, and sleep deprivation and 
disturbance may be reduced by resolving PTSD symptom severity.  BB provides a 
session dedicated to sleep hygiene.   
OVERVIEW OF CURRENT STUDY 
The current study investigates whether BB, a new cognitive enhancement 
group therapy, improves symptoms of PTSD, depression, and insomnia among 
veterans completing the groups.  The goal of this research was to assess the 
effectiveness of BB. 
Hypotheses 
H1:  PTSD symptoms will show statistically significant improvement from pre- 
to post-treatment. 
H2:  Depression symptoms will show statistically significant improvement from 
pre- to post-treatment. 
H3:  Insomnia symptoms will show statistically significant improvement from 
pre- to post-treatment. 
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METHOD 
Participants 
 The present study consisted of 64 US military veterans (n= 64), who 
served in or after World War II (WWII), were treated in the setting of the 
Veterans Affairs (VA) Health Care System in Phoenix, AZ, who took part in BB 
groups between 2007 and 2011.  Participants were recruited via referral from 
neuropsychologists, mental health workers, primary care physicians, social 
workers, and recruitment flyers posted within the Phoenix VA Hospital (Bushnell 
and Goren, 2011).  Data from 16 groups were used.  Participants attended an 
average of 8 of the 10 sessions offered, ranging from 1 to 10 sessions, with a 
mean of 8.02 sessions attended per participant (SD = 1.780).  
For each of the first sessions of BB (i.e. across all groups) a total of 207 
individuals attended.  Upon removal of those who did not continue with treatment 
or who did not complete measures, 179 remained (As noted below, completing 
measures was not required.)  Some of the individuals in the groups who 
completed measures were wives or other family members/friends who attended to 
provide social support to the veteran attending.  These individuals were then 
removed, resulting in 159 participants.  Next, individuals who did not complete at 
least one pre- and post-measure of interest, including the PCL-M, PHQ-9 and ISI, 
were removed, resulting in a sample size of 64 veterans.   
Finally, each item was measured individually.  For the PCL-M, 18 
individuals were removed, because they had not completed every pre- and post-
measure item in the PCL-M.  46 veterans were run in this analysis.  For the PHQ-
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9, 8 individuals were removed, because they had not completed every pre- and 
post-measure item in the PHQ-9.  56 veterans were run in this analysis. For the 
ISI, 12 individuals were removed, because they had not completed every pre- and 
post-measure item in the ISI.  52 veterans were run in this analysis.     
The mean age of sample participants was 53.47 years of age (SD= 13.73), 
spanning between 22 and 87 years of age; 21 participants did not report age.  
There were 48 participants who reported ethnicity.  Overall, participants were 
predominantly Caucasian (87.5%), followed by Black or African American 
(4.2%) and Hispanic or Latino (4.2%), and American Indian (2.1%) and Native 
Hawaiian or Pacific Islander (2.1%); 16 participants did not report ethnicity.     
Procedure 
 All procedures were approved by the Phoenix VA Healthcare System 
institutional review board. 
Brain Boosters groups. Veterans who attended the first session of BB 
were invited to fill out pre measures of mental-health related symptoms, 
including: the PTSD Checklist (PCL-M), Patient Health Questionnaire (PHQ-9), 
and Insomnia Severity Index (ISI).  Other measures not relevant to the present 
investigation were also administered (the Combat Exposure Scale [CES], 
Attention Process Training [APT-II], and an assessment of functional memory 
impairment [Strengths and Weaknesses (SW) scale].  Ten sessions of BB were 
administered to group members.  Sessions were facilitated primarily by 
neuropsychologists, with psychologists, nurses, speech therapists and social 
workers included as guest speakers (Bushnell and Goren, 2011). 
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BB consists of a ten week course with a 90 minute session each week.  
Week 1 is an introduction to the course, along with an overview of the 
curriculum; week 2 reviews general health and stress management; weeks 3 and 4 
address memory and new learning; week 5 reviews attention and neuroanatomy; 
week 6 addresses sleep hygiene; week 7 reviews executive functions; week 8 
addresses PTSD; week 9 discusses emotions, personality, and communication; 
week 10 is a ‘wrap-up’ (Goren and Bushnell, 2011).  
Each session is comprised of numerous topics or components.  A brief 
description of each session is as follows: During week 1, participants complete 
pre measures, go over disorders most prevalent among veterans, everyday living 
strategies, challenging the brain, promotion of maintenance and generalization, 
self-fulfillment, and resilience building.  During week 2, participants go over 
substance use, resiliency, exercise, nutrition, medication compliance, sleep, 
emotional well-being, and stress management.  During weeks 3 and 4, participants 
learn about various forms of memory, strategies for improving it, development of 
positive routines and habits to aid memory, metacognition, and new learning.  
During week 5, participants learn about various forms of attention, strategies for 
improving attention, modification of the environment, social support to improve 
attention, and neuroanatomical structure and functioning.  During week 6, 
participants review sleep hygiene, identifying hindrances to sleep quality and 
methods to overcome sleep dysfunction.  During week 7, participants examine 
executive functions, including: self-regulation, self-awareness, self-determination, 
self-control, self-management, self-direction, maturation, personality changes, 
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motivation, and goal setting.  During week 8, PTSD is highlighted.  Participants 
review prevalence of the disorder, fight or flight response, repeated stress, 
neurobiology, risk factors, diagnostic criteria, poor health outcomes, 
comorbidities, TBI, and adaptation to PTSD.  Week 9 is an overview of emotion, 
personality and communication.  Week 9 addresses emotion regulation, anger, 
personality, sense of self, forms of communication, and listening.  Week 10 is a 
‘wrap up’ session designed to review prior sessions, complete post measures, 
discuss personal insights, strengths and weaknesses recognized by the individual 
and as they pertain to BB, and to make referrals for future treatment (Goren and 
Bushnell, 2011).    
Upon completion of BB therapy, veterans are invited to fill out post 
measures of mental-health related symptoms, including the measures mentioned 
above, except for the CES.  They are also invited to provide feedback about BB 
with a Group Evaluation form.  The Group Evaluation form is a powerful way to 
assess the effectiveness of BB from the patient’s perspective, potentially allowing 
for the design and implementation of improved therapy.  Participants are 
encouraged to complete pre and post measures; however, it is not a requirement.  
Participants are told that if at any point they feel uncomfortable answering a 
question, especially those related to combat exposure, to stop and skip to the next 
item or measure they feel comfortable with.   
Chart review. Pre and post measures from the BB sessions were entered 
into an Excel database.  Charts were reviewed to identify demographic 
information, group membership, and number of sessions attended.  A de-
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identified dataset that included both pre-and post-treatment measures (described 
below) and demographic information (e.g., age, gender, ethnic background) was 
created.     
Measures and Data Reduction 
 The present study attempts to examine PTSD symptom severity and 
provisional diagnoses of PTSD, based on PTSD symptom severity and diagnostic 
scoring established in previous literature.  Self-report pre- and post-measures 
were used to assess symptom severity and provisional diagnoses in BB.  
Therefore, the word ‘provisional’ is used in reference to diagnosis, because 
diagnoses were not made by a clinician who had conducted a clinical structured 
diagnostic interview.  
PTSD Checklist (PCL-M) (Weathers, Litz, Herman, Huska, and Keane, 
1993). The PCL-M is one of the most commonly used self report measures of 
PTSD, anchoring to stressful military experiences.  Anchoring, meaning relating 
to stressful military experiences.  It is a 17 item, self-report measure of PTSD 
symptom severity.  The PCL-M uses a Likert scale with the following scale 
anchors to indicate how much a person has been bothered by each item in the past 
month: 1 (not at all), 2 (A little bit), 3 (Moderately), 4 (Quite a bit), and 5 
(Extremely).  Items reflect symptoms for PTSD as outlined in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV).  The PCL-M can be completed 
in approximately 5 minutes.  A total symptom severity score (range= 17-85) can 
be obtained by summing the scores from each of the 17 items.  A cut off score of 
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50 has been successful in diagnosing PTSD in Vietnam era veterans and 
recommended for use with OEF/OIF veterans (Barrett et al., 2002).   
A provisional diagnosis of PTSD also can be made from the PCL-M by 
determining whether an individual meets DSM-IV symptom criteria, i.e., a score 
of 3 or more on at least 1 B item (questions 1-5), 3 C items (questions 6-12), and 
2 D items (questions 13-17).  By using this scoring method in conjunction with a 
cut-off score of 50 described above, it ensures that the individual has experienced 
sufficient symptom severity as well as that they meet the necessary symptom 
patterns for diagnosis, required by the DSM-IV (Wilkins, Lang, and Norman, 
2011).  Thus, the present analyses use the provisional diagnostic criteria in 
addition to total symptom scores to evaluate the effectiveness of BB treatment.     
 Patient Health Questionnaire-9 (PHQ-9) (Kroenke, Spitzer, and 
Williams, 2001). The PHQ-9 is a 9 item, self-report measure of depression 
symptom severity from the Patient Health Questionnaire, which assists primary 
care clinicians in diagnosing depression and monitoring treatment.  Items are 
keyed to the diagnostic criteria for Major Depressive Episodes in the DSM-IV.  
Each of the 9 DSM-IV criteria is rated between 0 (not at all) and 3 (nearly every 
day).  Possible total scores on this measure therefore range from 0 to 27 points.  
PHQ-9 symptom severity scores fall into the following categories: 1-4 (minimal 
depression), 5-9 (mild depression), 10-14 (moderate depression), and 15-19 
(moderately severe depression), and 20-27 (severe depression).  Scores that fall 
within the moderate to severe categories constitute a diagnosis of MDD.  A 
provisional diagnosis is given, upon which treatment recommendations are made 
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(Kroenke et al., 2012).  The present analyses use these provisional diagnoses of 
MDD (i.e. scores that fall within the moderate to severe depression categories) as 
well as total symptom severity scores to evaluate the effectiveness of BB.   
 Insomnia Severity Index (ISI) (Morin, Belleville, Belanger, and Ivers, 
2011). The ISI is a brief self-report instrument to assess a person’s perception of 
his/her insomnia using seven items with a Likert-type response format.  The ISI 
items partially address the diagnostic criteria for Primary Insomnia in the DSM-
IV and the International Classification of Sleep Disorders (ICSD).  The patient is 
asked to think about their sleep over the past two weeks.  The ISI can be 
completed in less than 5 minutes.  Each item is rated on a 0-4 scale (4 indicating 
the greatest severity).  Each item has different wording for 0-4 scale.  For item 1, 
severity is measured as 0 (none), 1 (mild), 2 (moderate), 3 (severe) and 4 (very). 
For item 2, satisfaction is measured as 0 (very satisfied), 1-3 are continuous and 4 
(very dissatisfied).  For item 3, interference is measured as 0 (not at all 
interfering), 1 (a little), 2 (somewhat), 3 (much), 4 (very much interfering).  For 
item 4, how noticeable sleeping problems are, is measured as 0 (not at all 
noticeable), 1 (barely), 2 (somewhat), 3 (much) and 4 (very much noticeable).  
For item 5, worry is measured as 0 (not at all), 1 (a little), 2 (somewhat), 3 (much) 
and 4 (very much).  Total potential scores range from 0 to 28.  The symptom 
severity scores are categorized as follows: 0-7 (not clinically significant), 8-14 
(sub-threshold insomnia, 15-21 (moderate insomnia), and 22-28 (severe 
insomnia).  A six point reduction is recommended to represent clinically 
meaningful improvement for those with Primary Insomnia (Yang, Morin, 
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Schaefer, and Wallenstein, 2009).  For the present analyses, scores that fell within 
the moderate to severe insomnia categories were used to denote Primary 
Insomnia.  These scores as well as total symptom severity scores were used to 
evaluate the effectiveness of BB. 
Data Analysis 
 Hypothesis 1. To test hypothesis 1, that PTSD symptoms would show a 
statistically significant improvement from pre to post treatment, a paired samples 
t-test was run with PCL-M total score as the outcome measure.  In addition, 
McNemar’s Test, a non-parametric test for nominal data, was run to determine the 
proportion of participants who met criteria for a provisional diagnosis of PTSD at 
the outset of treatment versus at the end of treatment.   
 Hypothesis 2. To test hypothesis 2, that depression symptoms would show 
a statistically significant improvement from pre to post treatment, a paired 
samples t-test was run with total scores on the PHQ-9 as the outcome measure.  In 
addition, McNemar’s Test was run to determine the proportion of participants 
who met criteria for a provisional diagnosis of MDD at the outset of treatment 
versus at the end of treatment.  
 Hypothesis 3. To test hypothesis 3, that insomnia symptoms would show 
a statistically significant improvement from pre to post treatment, a paired 
samples t-test was run with total scores on the ISI as the outcome measure.  In 
addition, McNemar’s Test was run to determine the proportion of participants 
who met criteria for a provisional diagnosis of Primary Insomnia at the outset of 
treatment versus at the end of treatment. 
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RESULTS 
Hypothesis 1. PTSD symptom severity showed a statistically significant 
improvement from pre to post treatment, as seen in Table I and Figure I.  At time 
1 (T1) (pre-treatment), participants scored a mean of 54.83 (SD= 15.35) on the 
PCL-M.  At time 2 (T2) (post treatment), participants scored a mean of 51.35 
(SD= 14.74) on the PCL-M, t(45)= 2.78, p= 0.008, Cohen’s d= 0.231.  
Participants positive for provisional PTSD diagnoses at T1 showed a statistically 
significant improvement from pre to post treatment, N= 46, x²= 5.44, p= 0.039, as 
seen in Table II.  Of the 36 participants who had a provisional diagnosis of PTSD 
at T1, 8 of them did not at T2.  Eight participants met criteria for a provisional 
diagnosis of PTSD at T1 but no longer met diagnostic criteria at T2.  Of the 10 
participants who did not have a provisional diagnosis of PTSD at T1, 1 did at T2.  
McNemar’s Test results indicated, N= 46, x²= 5.44, p= 0.039, as seen in Table II.  
Twenty-eight participants met criteria for a provisional diagnosis of PTSD at both 
T1 and T2.  Nine participants did not meet criteria for a provisional diagnosis of 
PTSD at T1 or T2, as seen in Table III.   
Hypothesis 2. Depression symptom severity showed a statistically 
significant improvement from pre to post treatment, as seen in Table I and Figure 
I.  At time T1, participants scored a mean of 15.21 (SD= 7.79) on the PHQ-9.  At 
T2, participants scored a mean of 13.05 (SD= 6.35) on the PHQ-9, t(55)= 3.32, p= 
0.002, Cohen’s d= 0.304.  Participants positive for provisional MDD diagnoses at 
T1 did not show a statistically significant improvement from pre to post 
treatment, N=56, x²= 0.50, p= 0.727, as seen in Table II.  Of the 41 participants 
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who had a provisional diagnosis of MDD at T1, 5 of them did not at T2.  Five 
participants met criteria for a provisional diagnosis of MDD at T1 but no longer 
met diagnostic criteria at T2.  Of the 15 participants who did not have a 
provisional diagnosis of PTSD at T1, 3 did at T2.  McNemar’s Test results 
indicated, N= 56, x²= 0.50, p= 0.727, as seen in Table II.  Thirty-six participants 
met criteria for a provisional diagnosis of MDD at both T1 and T2.  Twelve 
participants did not meet criteria for a provisional diagnosis of MDD at T1 or T2, 
as seen in Table IV. 
Hypothesis 3. Insomnia symptom severity did not show a statistically 
significant improvement from pre to post treatment, as seen in Table I and Figure 
I.  At time T1, participants scored a mean of 15.98 (SD= 6.89) on the ISI.  At T2, 
participants scored a mean of 14.46 (SD= 7.08) on the ISI, t(51)= 1.96, p= 0.056 
(2 tailed), Cohen’s d= 0.218, as seen in Table II.  Participants positive for 
provisional Primary Insomnia diagnoses at T1 did not show a statistically 
significant improvement from pre to post treatment, N= 52, x²= 2.57, p= 0.180 (2 
sided).  Of the 32 participants who had a provisional diagnosis of Primary 
Insomnia at T1, 10 of them did not at T2.  Ten participants met criteria for a 
provisional diagnosis of Primary Insomnia at T1 but no longer met diagnostic 
criteria at T2.  Of the 20 participants who did not have a provisional diagnosis of 
Primary Insomnia at T1, 4 did at T2. McNemar’s Test results indicated, N= 52, 
x²= 2.57, p= 0.180 (2 sided).  Twenty-two participants met criteria for a 
provisional diagnosis of Primary Insomnia at both T1 and T2.  Sixteen 
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participants did not meet criteria for a provisional diagnosis of Primary Insomnia 
at T1 or T2, as seen in Table V. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
DISCUSSION 
 This study investigated whether Brain Boosters (BB), a new cognitive 
enhancement group therapy, would improve symptoms of PTSD, depression, and 
insomnia among veterans completing the groups.  The goal of this research was to 
assess the effectiveness of BB.  Paired samples t-tests were run to determine the 
effectiveness of BB for treating PTSD, depression and insomnia symptom 
severity.  Results supported the hypotheses that symptoms of PTSD and 
depression would improve significantly.  Results did not support the hypothesis 
that symptoms of insomnia would improve significantly.  McNemar’s Tests were 
run to determine the effectiveness of BB for significantly reducing the number of 
participants who met criteria for provisional diagnoses for PTSD, depression, and 
insomnia.  Results of these tests supported the hypothesis that provisional 
diagnoses of PTSD would decrease from pre to post treatment.  The hypotheses 
that provisional diagnoses of depression and insomnia would show a significant 
decrease post treatment were not supported.  These results suggest BB may be 
effective for reducing PTSD and depression symptom severity, along with 
provisional diagnoses of PTSD.   
Evaluating Clinically-Meaningful Change  
Two different ways of assessing participant data were used: symptom 
severity and provisional diagnoses (i.e., diagnoses based on self-report measures 
rather than clinical interviews).  The rationale for assessing symptom severity, 
along with changes in provisional diagnoses is to assess PTSD with the highest 
possible chance of maintaining clinically-meaningful findings.  The PCL-M is 
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reflective of the theory that using both methods of assessment for PTSD is ideal.  
The PCL-M can be scored in two ways: by summing the scores from each of the 
17 items for a symptom severity score, or by keying items to the DSM-IV for a 
score that falls within a certain diagnostic category.  Scoring the PCL-M each way 
provides a more global view of PTSD, including symptom severity and diagnosis.  
Interestingly, in the analysis for the present study, using a cut off score for 
symptom severity of 50 and above, when diagnosing PTSD, versus the diagnostic 
categories from moderate to severe, the symptom severity score was more 
sensitive and thus, more stringent for diagnosing participants with PTSD.  Prior 
studies have done this, such as one by conducted by Pietrzak and colleagues that 
only studied respondents who met a symptom severity score of 50 or greater and 
had moderate to severe ratings for enough DSM-IV criteria to indicate a 
provisional diagnosis of PTSD.  They note that this definition provides a 
conservative estimate of the PTSD prevalence (Pietrzak et al., 2009).          
Potential Mechanisms for BB Effectiveness 
BB was not designed specifically for any one disorder; rather, it was 
devised to improve overall functioning in veterans seeking treatment and to aid 
veterans in attaining improved quality of daily life.  BB was initiated when 
creators, neuropsychologists, Dr. Goren and Dr. Bushnell, saw a need for 
improved treatment for OEF/OIF veterans, returning with symptoms of PTSD, 
TBI, cognitive impairments and difficulty functioning (Goren and Bushnell, 
2011).  Again, although BB is not solely targeted to treat PTSD, it was developed 
with PTSD at present of mind.  Only one session of the ten week course is 
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devoted to PTSD; however, throughout the course, strategies are taught to 
properly cope with functional impairments and symptoms associated with PTSD. 
 Similarly, although BB was not designed to address symptoms of 
depression per se, strategies taught throughout the course may be helpful for 
reducing depression symptom severity.  Positive forms of coping, such as 
approach coping and social support seeking are encouraged during the groups and 
may minimize depression symptom severity by revising global, stable, internal, 
negative beliefs.  Cultivating self-efficacious attitudes and behaviors provide 
additional means to achieving wellness. Psychoeducation empowers participants 
with knowledge about their deficits and ways to overcome them, focusing on their 
strengths.  Peer support also may have played a large role in decreasing 
depressive symptoms.  An unexpected finding was that BB is not effective for 
significantly reducing provisional diagnoses of depression.  This may have been 
the case, in contrast to the finding that BB is effective for reducing depression 
symptom severity, because to meet criteria for a diagnosis of MDD from the 
PHQ-9, a moderate to severe score is required.  Therefore, decreases in symptom 
severity were apparent, but decreases in provisional diagnoses were not, 
considering that it is more difficult to jump from one scoring category to another, 
especially for participants with moderate to severe depression.   
BB is not effective for statistically significantly reducing insomnia 
symptom severity or provisional diagnoses of insomnia.  Ten participants began 
treatment with provisional diagnosis of insomnia and completed treatment 
without meeting criteria for such a diagnosis.  In addition, although not 
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significant, there was a statistical trend toward decreased insomnia symptoms 
from pre- to post-treatment.  Therefore, BB may have had some influence on 
veterans’ sleep.  One session was offered reviewing sleep hygiene.  A potential 
reduction in insomnia symptoms also may be attributed to reduction in PTSD and 
depression symptom severity, as insomnia, depression, and PTSD share 
interrelated symptoms.       
Dunn and colleagues point out core psychological features of PTSD and 
depression are shared, mentioning helplessness, social withdrawal, anhedonia and 
low self-esteem (Dunn et al., 2007).  Overlapping symptoms of PTSD and 
depression include irritability, concentration difficulties, mood disruptions, and 
perhaps even more psychological factors, such as a low sense of self worth, and 
feelings of guilt and shame; all of which are indirectly targeted through strategies 
taught in BB groups.   
BB and peer support. BB is potentially effective for decreasing PTSD 
and depression symptom severity, and provisional diagnoses of PTSD for many 
reasons.  First, peer support provides tremendous reassurance, validation, and 
understanding of feelings only experienced by those who have been to war, 
potentially enhancing feelings of self-efficacy, personal control, and meaning 
making, increasing veterans’ ability to reappraise stressful events (Pietrzak et al., 
2010).  The innate understanding of other warriors’ tribulations and experience 
allow for support unrivaled in strength.   
BB and social support. Second, encouragement from BB to seek out 
social support from family and friends is valuable. An invitation is given to 
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veterans to bring any form of social support to groups, including: family, friends, 
and loved ones.  The provision of early social support may reduce PTSD and 
comorbid conditions, postdeployment for OEF/OIF veterans (Pietrzak et al., 
2010).  Although most veterans were not recently returned OEF/OIF veterans, for 
those who were, BB may have been especially helpful.  For OEF/OIF/OND 
veterans, the implementation of treatment programs like BB immediately upon 
return home from deployment may reduce PTSD and comorbid disorder symptom 
severity, resulting in a more seamless transition to everyday life, away from 
theater. 
Familial support has also been found to reduce PTSD symptom severity 
across trauma levels (Laffaye et al., 2008).  Reliance on others for instrumental 
and emotional support is an integral piece of the puzzle to manage PTSD and 
depression symptom severity.     
BB and coping strategies. Next, resilient tendencies, such as meaning-
making, cognitive flexibility and focusing on positive emotions (Pietrzak et al., 
2010) are taught in BB.  Awareness and practice of advantageous forms of coping 
contribute to decreases in PTSD and depression symptom severity.  Veterans 
learn that they do not have to cope with negative symptomatology alone; 
approach coping can help.  Many veterans with PTSD are prone to practice 
avoidant coping, a hallmark of increased PTSD severity, while problem-focused 
coping reduces symptoms (Blake et al., 1992; Rodrigues et al., 2010; Tiet et al., 
2006; Wolfe et al., 1993).  BB emphasizes problem-focused coping.  Tackling 
daily obstacles through environmental modification, as simple as keeping your 
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keys in one place, reduces the frustration some veterans struggle with (Goren and 
Bushnell, 2011).  Curtailing the cumulative effect of daily life hassles may 
mitigate frustration and feelings of anger and irritability.  
BB and self-efficacy. Low self-efficacy is found more often in individuals 
who have PTSD versus those who do not have PTSD (Benight and Bandura, 
2004).  Self-efficacy regulates functioning through decisional, motivational, 
cognitive and affective processes, thereby dictating the quality of our emotional 
lives, willingness to persevere and the choices we are faced to make (Benight and 
Bandura).  Relative to self-efficacy, Seligman, Abramson, Semmel, and Baeyer 
(1979) introduced the depressive attributional style, maintaining that attributing 
lack of control to internal factors lead to lowered self esteem.  The realization that 
we are responsible for our own thoughts, and do have some control of our 
feelings, actions, attitudes and behaviors is empowering.  BB offers a session on 
executive functioning, which relates to self-efficacy (Goren and Bushnell, 2011).  
Perceived self-efficacy likely combats depressive symptomatology, especially 
feelings of helplessness.   
BB, cognitive enhancement, psychoeducation and CBT. The 
components of BB related to cognitive enhancement and psychoeducation may 
decrease PTSD and depression symptom severity, as well.  Cognitive 
enhancement addresses the need for improvement in processing speed, cognitive 
style, social cognition and social adjustment.  Psychoeducation promotes 
experiential learning and self empowerment.  A psychoeducational group format, 
administered by Dunn et al. (2007) included didactic discussions and information 
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about the causes, treatment and nature of PTSD and depression, akin to BB.  
Participants rated this therapy as being high in clarity, helpfulness, and positive 
group environment.  BB also borrows from previous treatment methods like CBT.  
The ability to restructure negative thought processes with more positive ones and 
become goal oriented versus inwardly focused, is conceivably important for 
decreasing PTSD and depression symptom severity.      
BB and improved functioning. Once veterans learn it is possible to 
improve one area of functioning, they may be more likely to participate in other 
tasks or activities to improve areas of their lives, like vocational rehabilitation, 
psychotherapy, BB splinter groups and other treatment groups offered at the VA. 
They may be more willing to seek out help because behavioral activation (BA) 
therapy mimicked in BB, works to treat depression, lifting mood and mitigating 
the cycle of learned helplessness.  BA focuses on the assessment and treatment of 
avoidant behaviors, promoting regular routines and structuring of daily activities.  
Most importantly, patterns of avoidance and withdrawal related to interpersonal 
situations are targeted (Dimidjian et al., 2006).  Practical factors, consistent with 
newly attained knowledge of how to navigate the VA system and relational 
factors, such as trusting providers may lead to increases in treatment seeking and 
ultimately, improved functioning.  As corroborated by the creators of BB, upon 
completion, veterans are more willing to seek out and receive support from other 
veterans, friends, and family (Bushnell and Goren, 2011).   
The finding that BB is effective for reducing PTSD and depression 
symptom severity, along with provisional diagnoses of PTSD is an exciting one.  
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The time and effort put into developing BB now has analyses to support the 
effectiveness of this new treatment for reducing PTSD and depression symptom 
severity and provisional diagnoses of PTSD. 
Limitations 
The present study has several limitations.  Self report measures were used, 
and therefore are open to differences in interpretation, memory issues, the halo 
effect and social desirability bias.  Symptom severity and provisional diagnoses 
were made based on pre- and post-measures, not structured clinical diagnostic 
interviews. Diagnoses made by healthcare professionals were not taken into 
account in the present study.     
Participants attended an average of 8 of the 10 sessions offered with a 
mean of 8.02 sessions attended per participant (SD = 1.780).  Thus, certain 
material was missed, potentially altering responses to post measures and treatment 
outcomes.  This study captured a non-random subset of veterans who participated 
in the groups and not only were willing to complete questionnaire measures, but 
did so both pre-and post treatment.  Therefore, generalizability to other samples of 
veterans may be limited.  
Individual and within participant differences also pose a limitation to this 
study.  An incredibly wide age range of veterans presented for treatment, between 
22 and 87 years with a mean age of 53.47 years old (SD= 13.73).  Generational 
differences and war era differences, along with cohort effects may affect group 
therapy.  Veterans who served in or after World War II (WWII) made up the BB 
groups.  Reportedly, per the facilitators of the group, veterans from different eras, 
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who fought in different wars, and who were of varying ages, got along, 
complementing each other with personal experiences, stories, and advice.  The 
relationships formed in BB between OEF/OIF/OND veterans, along with those 
formed with older veterans appeared to be of value to participants.  However, as 
stated above, individual differences may have affected treatment.  Sessions 
attended, number of sessions attended, level of combat exposure, and amount of 
time since being in a war zone are a few of the variables that may have 
contributed to individual differences.   
There are also potential differences between groups, which may pose a 
limitation to this study.  Factors like mean age, number of sessions provided, and 
personality factors may have resulted in different outcomes between groups.  Per 
the creators of BB, groups seemed to take on personalities of their own.  
Consequently, no two groups were the same.     
The halo effect may have played a role in perception of treatment 
outcomes when post measures were collected.  An end of treatment halo effect, 
described by Thorndike (1919) refers to the phenomenon that self report measure 
improvement is typically rated as higher immediately following intervention.  
These effects may not translate into long term gains.    
Next, there was no control group in this study; all participants received the 
same treatment with BB.  Therefore, it cannot be determined whether the 
reduction seen in PTSD and depression symptom severity and provisional 
diagnoses of PTSD were a result of BB treatment or of a natural improvement 
over time.  Also, this study only analyzed data from veterans, but the presence of 
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wives and social support at the groups may have altered interaction between 
veterans.   
Finally, comorbid disorders, such as substance abuse or schizophrenia and 
chronic medical conditions, such as diabetes, may have had an effect on treatment 
outcomes.  For certain individuals, improvement or deterioration in one area of 
functioning or of one disorder or condition may have had an effect on BB 
treatment results. 
This is just the beginning for BB in terms of learning which aspects of BB 
constitute the greatest improvements in symptom severity for PTSD, depression, 
and insomnia.  Future work with BB may entail a greater focus on tools to 
improve insomnia symptom severity and understanding what about BB improves 
PTSD and depression.  Based on preliminary analyses run to explore the 
effectiveness of BB for treating PTSD, depression, and insomnia it is a hope that 
the results obtained may guide the creators of BB in recognizing the strengths of 
the program and honing areas in which there is greater potential for symptom 
improvement.     
Implications 
The results of this study have potential implications for treatment of 
veterans with PTSD and depression, as well as civilians.  A recent study related to 
treating veterans with opioids emphasized the importance of alternative 
treatments to pharmacological intervention for PTSD (Seal et al., 2012).  Brain 
Boosters may be one such treatment.  They highlighted the challenge of treating 
veterans with haunting memories of war and devastating physical injuries and 
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state that physicians treating veterans should offer less risky treatment, including 
therapies other than drugs (Seal et al.).  BB is an excellent example of a less risky 
form of treatment, because it is strictly therapeutically based, eliminating the risk 
of harmful side effects from pharmacological interventions like the prescription of 
opioids, beta blockers, anti-depressants, anti-anxiolytics, and even tranquilizers.  
Therapeutic interventions should be recognized as a primary or if necessary, 
complementary method to treating symptoms of PTSD and depression.   
Cognitive enhancement and psychoeducation for veterans to lessen PTSD 
symptom severity has been largely missing from the literature.  The analyses ran 
on this data set suggested that BB is effective for treating PTSD and depression 
symptom severity and provisional diagnoses of PTSD.   
These findings should encourage wider dissemination of BB therapy 
protocols to VA healthcare systems around the country.  Peer support for 
veterans, along with a treatment format emphasizing cognitive enhancement and 
psychoeducation is promising. The need for improved care for OEF/OIF/OND 
veterans returning from combat is urgent.  BB provides a foundation for new 
treatments to be modeled after to reduce PTSD and depression symptom severity.    
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Table I – Paired Samples T-Tests Results 
Symptom Severity 
Measures 
N Means (SD) 
Mean 
Difference 
(95% CI) 
p-value 
PCL-M 
     Time 1 
     Time 2 
 
46 
46 
 
54.84 (15.35) 
51.35 (14.74) 
 
3.489  
(0.963 to 6.015) 
 
 
0.008 
PHQ-9 
     Time 1 
     Time 2 
 
56 
56  
 
15.21 (7.79) 
13.05 (6.35) 
 
2.161 
(0.858 to 3.463) 
 
 
0.002 
ISI 
     Time 1 
     Time 2 
 
52 
52 
 
15.98 (6.89) 
14.46 (7.08) 
 
1.519 
(-0.038 to 3.076) 
 
 
0.056 
 
Table II – McNemar’s Tests Results 
Provisional 
Diagnoses 
Measures 
 
X² 
 
N p-value 
PCL-M 
 
 
5.44 
 
46 
 
 
0.039 
PHQ-9 
      
 
 
0.50 
 
56 
  
 
0.727 
ISI 
      
 
 
2.57 
 
52 
 
 
0.180 
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Table III – McNemar’s PCL-M Test Results  
 
 
 
PTSD Diagnosis 
Time 2 
 
  
PTSD Diagnosis 
Time 1 
 
No diagnosis 
(0) 
 
Diagnosis  
(1) 
 
 
Total 
No diagnosis 
(0) 
Count 9 
 
1 
 
10 
 
Diagnosis  
(1) 
Count 
 
8 
 
28 
 
36 
 
Total Count 17 
 
29 
 
48 
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Table IV – McNemar’s PHQ-9 Test Results  
 
 
 
MDD 
Diagnosis 
Time 2 
 
  
MDD Diagnosis Time 1 
 
No diagnosis (0) 
 
Diagnosis  
(1) 
 
 
Total 
No diagnosis 
(0) 
Count 12 
 
3 
 
15 
 
Diagnosis  
(1) 
Count 
 
5 
 
36 
 
41 
 
Total Count 17 
 
39 
 
56 
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Table V – McNemar’s ISI Test Results  
 
 
 
Primary 
Insomnia 
(PI) 
Diagnosis 
Time 2 
 
  
Primary Insomnia (PI) 
Diagnosis Time 1 
 
No diagnosis 
(0) 
 
Diagnosis  
(1) 
 
 
Total 
No diagnosis 
(0) 
Count 16 4 20 
Diagnosis  
(1) 
Count 
 
10 22 32 
Total Count 26 
 
26 52 
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APPENDIX C 
FIGURE I 
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Figure I – Symptom Severity Score Results for PCL-M, PHQ-9, and ISI  
 
Note.  
PCL-M, Posttraumatic Stress Disorder Checklist- Military Version. 
PHQ-9, Patient Health Questionnaire 9. 
ISI, Insomnia Severity Index. 
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APPENDIX D 
MEASURES 
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PCL-M Scoring 
 
There are 2 ways to score the PCL:  
• Add up all the items for a total severity score    
or  
•  Treat “moderately” or above (response 3 through 5) as symptomatic and 
anything  
below “moderately” (1 and 2) as non-symptomatic.  
• Then follow the DSM scoring rule to get a diagnosis.  That is:  
   •  You need an endorsement of at least 1 ‘B’ item (question #s 1-5)  
• You need an endorsement of at least 3 ‘C’ items (question #s 6-12)   
• You need an endorsement of at least 2 ‘D’ items (question #s 13-17) 
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PHQ-9 Patient Depression Questionnaire 
 
For initial diagnosis: 
1. Patient completes PHQ-9 Quick Depression Assessment. 
2. If there are at least 4 �s in the shaded section (including Questions #1 and #2), 
consider a depressive disorder. Add score to determine severity. 
 
Consider Major Depressive Disorder 
- If there are at least 5 �s in the shaded section (one of which corresponds to 
Question #1 or #2) 
 
Consider Other Depressive Disorder 
- If there are 2-4 �s in the shaded section (one of which corresponds to Question 
#1 or #2) 
Note: Since the questionnaire relies on patient self-report, all responses should be 
verified by the clinician, and a definitive diagnosis is made on clinical grounds 
taking into account how well the patient understood the questionnaire, as well as 
other relevant information from the patient. 
Diagnoses of Major Depressive Disorder or Other Depressive Disorder also 
require impairment of social, occupational, or other important areas of functioning 
(Question #10) and ruling out normal bereavement, a history of a Manic Episode 
(Bipolar Disorder), and a physical disorder, medication, or other drug as the 
biological cause of the depressive symptoms. 
 
To monitor severity over time for newly diagnosed patients or patients in 
current treatment for depression: 
1. Patients may complete questionnaires at baseline and at regular intervals (e.g., 
every 2 weeks) at 
home and bring them in at their next appointment for scoring or they may 
complete the questionnaire during each scheduled appointment. 
2. Add up �s by column. For every �: Several days = 1 More than half the days = 
2 Nearly every day = 3 
3. Add together column scores to get a TOTAL score. 
4. Refer to the accompanying PHQ-9 Scoring Box to interpret the TOTAL score. 
5. Results may be included in patient files to assist you in setting up a treatment 
goal, determining degree of response, as well as guiding treatment intervention. 
 
Scoring: add up all checked boxes on PHQ-9 
For every � Not at all = 0; Several days = 1; More than half the days = 2; Nearly 
every day = 3 
 
Interpretation of Total Score 
Total Score Depression Severity 
1-4 Minimal depression 
5-9 Mild depression 
68 
10-14 Moderate depression 
15-19 Moderately severe depression 
20-27 Severe depression 
 
PHQ9 Copyright © Pfizer Inc. All rights reserved. Reproduced with permission. 
PRIME-MD ® is a trademark of Pfizer Inc. 
A2662B 10-04-2005 
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Insomnia Severity Index 
Guidelines for Scoring/Interpretation: 
Add the scores for all seven items (questions 1 + 2 + 3 + 4 + 5 +6 + 7) = _______ 
your total score 
Total score categories: 
0–7 = No clinically significant insomnia 
8–14 = Sub-threshold insomnia 
15–21 = Clinical insomnia (moderate severity) 
22–28 = Clinical insomnia (severe) 
Print out your completed Insomnia Severity Index, along with the Guidelines 
for Scoring/Interpretation, to show to your health care provider. 
 
Used with permission from Charles M. Morin, Ph.D., Université Laval 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
 
 
 
 
72 
 
 
 
 
 
73 
 
 
 
 
 
 
74 
APPENDIX E 
DIAGNOSTIC CRITERIA 
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Post-Traumatic Stress Disorder. Criterion A, concerns the stressor itself, 
and both of the following must have been present: “The person has experienced, 
witnessed, or been confronted with an event or events that involve actual or 
threatened death or serious injury, or a threat to the physical integrity of oneself or 
others.  The person’s response involved intense fear, helplessness, or horror.” 
(DSM-IV TR, 2000)  Next, Criterion B through D detail the three symptom 
clusters: intrusive recollection, avoidant/numbing, and hyper-arousal, from each 
of which, the patient must report experiencing symptomatology to some degree.   
Criterion B pertains to the first of the three symptom clusters, intrusive 
recollection.  “The traumatic event is persistently re-experienced in at least one of 
the following ways: Recurrent and intrusive distressing recollections of the event, 
recurrent distressing dreams, acting or feeling as if the event were recurring, 
intense psychological distress, and physiological reactivity upon cues.” (DSM-IV 
TR, 2000)  Unpleasant memories, obsessive and compulsive thoughts, heightened 
stress response, increased reactivity, nightmares, dissociative states, flashbacks, 
and even hallucinations are characteristic of intrusive recollection.  Although 
there are three distinct symptom clusters, some overlap is found, specifically in 
physiological and psychological reactivity.  For example, physiological reactivity 
upon cues or triggers of the traumatic event in the intrusive recollection cluster 
are likely to incur uncomfortable physical sensations similar to the hyper-
vigilance, and exaggerated startle response, found in the hyper-arousal cluster. 
Much of the avoidant/numbing cluster seems to parallel depressive symptoms.     
 Criterion C pertains to the symptom cluster, avoidant/numbing.  
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“Persistent avoidance of stimuli associated with the trauma and numbing in 
general responsiveness (not present before the trauma), as indicated by at least 
three of the following: Efforts to avoid thoughts, feelings, and conversations 
associated with the trauma; activities, places, and people that arouse recollections 
of the trauma;  inability to recall an important aspect of the trauma; markedly 
diminished interest or participation in significant activities; feelings of 
detachment or estrangement from others; restricted range of affect; [and] sense of 
a foreshortened future.” (DSM-IV TR, 2000)  The symptoms associated with 
avoidance and numbing can contribute to feelings of loneliness, helplessness, and 
hopelessness; all associated with depression, a disorder highly comorbid with 
PTSD. Entrenchment in the individuals PTSD psychopathology, coupled with 
avoidance of triggers, including people, places, and things heightens isolation, 
leading to the potential for increased symptom severity, and decreased social 
support, resultant from withdrawal from others.  In contrast to the 
avoidant/numbing cluster, the third and final symptom cluster.      
Criterion D pertains to the symptom cluster, hyper-arousal.  “Persistent 
symptoms of increasing arousal (not present before the trauma), indicated by at 
least two of the following: Difficulty falling or staying asleep, irritability or 
outbursts of anger, difficulty concentrating, hyper-vigilance, and exaggerated 
startle response.” (DSM-IV TR, 2000)  The hyper-arousal symptoms can make 
daily tasks more difficult, resulting in decreased efficiency, productivity, and 
ultimately, self-efficacy.  The debilitating nature of some of these symptoms, 
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along with negative symptomatology associated with Criterion B and C, can lead 
to adverse events, marked by psychological and physiological consequences.  
 Criterion E pertains to duration and requires that symptoms from the 
above clusters have been present for at least a month.   
   Lastly, Criterion F relates to functional significance.  “The disturbance 
causes clinically significant distress or impairment in social, occupational, or 
other important areas of functioning.” (DSM-IV TR, 2000)  PTSD can be acute, 
lasting less than six months or chronic, lasting more than six months. Symptom 
onset should also be considered. Markers of the disorder may be evident at the 
time of the trauma or at least six months after the traumatic event (DSM-IV TR, 
2000).   
Major Depressive Episode.  Criterion A requires that five or more of the 
following nine symptoms are present during the same two week period and 
indicate a change from previous functioning.  At least one of the nine symptoms 
must be depressed mood or loss of interest or pleasure. (DSM-IV TR, 2000)   
 Symptom 1: “Depressed mood most of the day, nearly every day, as 
indicated by either subjective report (e.g., feels sad or empty) or observation made 
by others (e.g. appears tearful).”  Symptom 2: “Markedly diminished interest or 
pleasure in all, or almost all, activities most of the day, nearly every day (as 
indicated by either subjective account or observation made by others).”  Symptom 
3: “Significant weight loss when not dieting or weight gain (e.g. a change of more 
than 5% of body weight in a month), or decrease or increase in appetite nearly 
every day.”  Symptom 4: “Insomnia or hypersomnia nearly every day.”  Symptom 
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5: “Psychomotor agitation or retardation nearly every day (observable by others, 
not merely subjective feelings of restlessness or being slowed down).”  Symptom 
6: “Fatigue or loss of energy nearly every day.”  Symptom 7: “Feelings of 
worthlessness or excessive or inappropriate guilt (which may be delusional) 
nearly every day (not merely self-reproach or guilt about being sick).”  Symptom 
8: “Diminished ability to think or concentrate, or indecisiveness, nearly every day 
(either by subjective account or as observed by others).”  Symptom 9: “Recurrent 
thoughts of death (not just fear of dying), recurrent suicidal ideation without a 
specific plan, or a suicide attempt or a specific plan for committing suicide.” 
(DSM-IV TR, 2000)   
 Criterion B posits that these symptoms do not meet criteria for a mixed 
episode.  Criterion C states that symptoms must cause clinically significant 
impairment and distress in important areas of functioning, such as social and 
occupational functioning.  Criterion D states that symptoms are not directly 
caused by the use of a substance or effects of a general medical condition.  
Finally, criterion E says that the symptoms cannot be better accounted for by 
bereavement (DSM-IV TR, 2000).    
 Major Depressive Disorder. Major depressive disorder is characterized 
by the presence of a Major Depressive Episode.  This episode cannot be better 
accounted for by another disorder and the patient must never have had a manic 
episode, mixed episode, or a hypomanic episode (DSM-IV TR, 2000).  The PHQ-
9 does not test for a specific type of depression.  Upon completing the PHQ-9, the 
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measurement should indicate to the provider whether or not the patient is 
experiencing any number of depressive disorders.    
 Primary Insomnia. Insomnia is a symptom of both PTSD and depression.  
Primary insomnia requires five prerequisites for diagnosis.  Criterion A: “The 
predominant complaint is difficulty initiating or maintaining sleep, or 
nonrestorative sleep, for at least one month.” (DSM-IV TR, 2000)  Criterion B: 
“The sleep disturbance (or associated daytime fatigue) causes clinically 
significant distress or impairment in social, occupational, or other important areas 
of functioning.” (DSM-IV TR, 2000)  Criterion C: “The sleep disturbance does 
not occur exclusively during the course of Narcolepsy, Breathing-Related Sleep 
Disorder, Circadian Rhythm Sleep Disorder, or a Parasomnia.” (DSM-IV TR, 
2000)  Criterion D: “The disturbance does not occur exclusively during the course 
of another mental disorder (e.g. Major Depressive Disorder, Generalized Anxiety 
Disorder, a delirium).” (DSM-IV TR, 2000)  Last, Criterion E: “The disturbance 
is not due to the direct physiological effects of a substance (e.g., a drug of abuse, a 
medication) or a general medical condition.” (DSM-IV TR, 2000)  Insomnia may 
be diagnosed independently of another disorder or as a symptom of disorders like 
Major Depressive Disorder or Post-Traumatic Stress Disorder. 
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APPENDIX F 
INSTITUTIONAL REVIEW BOARD (IRB) APPROVAL: PHOENIX VA  
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